110 related articles for article (PubMed ID: 30720118)
21. CADM2, as a new target of miR-10b, promotes tumor metastasis through FAK/AKT pathway in hepatocellular carcinoma.
Li D; Zhang Y; Zhang H; Zhan C; Li X; Ba T; Qiu Z; E F; Lv G; Zou C; Wang C; Si L; Zou C; Li Q; Gao X
J Exp Clin Cancer Res; 2018 Mar; 37(1):46. PubMed ID: 29506532
[TBL] [Abstract][Full Text] [Related]
22. Identification of invasion-metastasis-associated microRNAs in hepatocellular carcinoma based on bioinformatic analysis and experimental validation.
Lou W; Chen J; Ding B; Chen D; Zheng H; Jiang D; Xu L; Bao C; Cao G; Fan W
J Transl Med; 2018 Sep; 16(1):266. PubMed ID: 30268144
[TBL] [Abstract][Full Text] [Related]
23. HOXA-AS2 Promotes Proliferation and Induces Epithelial-Mesenchymal Transition via the miR-520c-3p/GPC3 Axis in Hepatocellular Carcinoma.
Zhang Y; Xu J; Zhang S; An J; Zhang J; Huang J; Jin Y
Cell Physiol Biochem; 2018; 50(6):2124-2138. PubMed ID: 30415263
[TBL] [Abstract][Full Text] [Related]
24. MicroRNA-302a targets GAB2 to suppress cell proliferation, migration and invasion of glioma.
Ma J; Yu J; Liu J; Yang X; Lou M; Liu J; Feng F; Ji P; Wang L
Oncol Rep; 2017 Feb; 37(2):1159-1167. PubMed ID: 28000880
[TBL] [Abstract][Full Text] [Related]
25. MicroRNA‑340 inhibits tumor cell proliferation, migration and invasion, and induces apoptosis in hepatocellular carcinoma.
Wang Z; Song D; Huang P
Mol Med Rep; 2017 Nov; 16(5):7649-7656. PubMed ID: 28944918
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA‑144 suppresses tumorigenesis of hepatocellular carcinoma by targeting AKT3.
Ma Y; She XG; Ming YZ; Wan QQ; Ye QF
Mol Med Rep; 2015 Feb; 11(2):1378-83. PubMed ID: 25370363
[TBL] [Abstract][Full Text] [Related]
27. Downregulation of miR-329 promotes cell invasion by regulating BRD4 and predicts poor prognosis in hepatocellular carcinoma.
Zhou J; Li W; Guo J; Li G; Chen F; Zhou J
Tumour Biol; 2016 Mar; 37(3):3561-9. PubMed ID: 26456956
[TBL] [Abstract][Full Text] [Related]
28. Long non‑coding RNA HOXA11‑AS accelerates cell proliferation and epithelial‑mesenchymal transition in hepatocellular carcinoma by modulating the miR‑506‑3p/Slug axis.
Liu Y; Yan W; Zhou D; Jin G; Cheng X
Int J Mol Med; 2020 Nov; 46(5):1805-1815. PubMed ID: 32901858
[TBL] [Abstract][Full Text] [Related]
29. microRNA-146a inhibits cancer metastasis by downregulating VEGF through dual pathways in hepatocellular carcinoma.
Zhang Z; Zhang Y; Sun XX; Ma X; Chen ZN
Mol Cancer; 2015 Jan; 14():5. PubMed ID: 25608619
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA-424-5p acts as a potential biomarker and inhibits proliferation and invasion in hepatocellular carcinoma by targeting TRIM29.
Du H; Xu Q; Xiao S; Wu Z; Gong J; Liu C; Ren G; Wu H
Life Sci; 2019 May; 224():1-11. PubMed ID: 30876939
[TBL] [Abstract][Full Text] [Related]
31. MicroRNA‑577 inhibits the migration and invasion of hepatocellular carcinoma cells by targeting homeobox A1.
Han S; Liu Z; Wang Y; Wang L; Yao B; Guo C; Song T; Tu K; Liu Q
Oncol Rep; 2018 Jun; 39(6):2987-2995. PubMed ID: 29693150
[TBL] [Abstract][Full Text] [Related]
32. EZH2 promotes hepatocellular carcinoma progression through modulating miR-22/galectin-9 axis.
Chen S; Pu J; Bai J; Yin Y; Wu K; Wang J; Shuai X; Gao J; Tao K; Wang G; Li H
J Exp Clin Cancer Res; 2018 Jan; 37(1):3. PubMed ID: 29316949
[TBL] [Abstract][Full Text] [Related]
33. Long non-coding RNA CASC2 suppresses epithelial-mesenchymal transition of hepatocellular carcinoma cells through CASC2/miR-367/FBXW7 axis.
Wang Y; Liu Z; Yao B; Li Q; Wang L; Wang C; Dou C; Xu M; Liu Q; Tu K
Mol Cancer; 2017 Jul; 16(1):123. PubMed ID: 28716020
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA-363-3p is downregulated in hepatocellular carcinoma and inhibits tumorigenesis by directly targeting specificity protein 1.
Ying J; Yu X; Ma C; Zhang Y; Dong J
Mol Med Rep; 2017 Aug; 16(2):1603-1611. PubMed ID: 28627662
[TBL] [Abstract][Full Text] [Related]
35. MicroRNA-32 Regulates Development and Progression of Hepatocellular Carcinoma by Targeting ADAMTS9 and Affects Its Prognosis.
Li S; Li T; Li X; Yao Y; Jiang X; Zhao L; Guo W
Med Sci Monit Basic Res; 2018 Nov; 24():177-187. PubMed ID: 30393368
[TBL] [Abstract][Full Text] [Related]
36. Expression Pattern and Clinical Significance of Gab2 Protein in Hepatocellular Carcinoma.
Hu X; He B; Zhou L; Xie H; Zheng S
Clin Lab; 2016; 62(6):1087-92. PubMed ID: 27544933
[TBL] [Abstract][Full Text] [Related]
37. Expression and function of microRNA-27b in hepatocellular carcinoma.
He S; Zhang J; Lin J; Zhang C; Sun S
Mol Med Rep; 2016 Mar; 13(3):2801-8. PubMed ID: 26846382
[TBL] [Abstract][Full Text] [Related]
38. miR-224 promotion of cell migration and invasion by targeting Homeobox D 10 gene in human hepatocellular carcinoma.
Li Q; Ding C; Chen C; Zhang Z; Xiao H; Xie F; Lei L; Chen Y; Mao B; Jiang M; Li J; Wang D; Wang G
J Gastroenterol Hepatol; 2014 Apr; 29(4):835-42. PubMed ID: 24219032
[TBL] [Abstract][Full Text] [Related]
39. [Over-expression of miR-141 inhibits the proliferation, invasion and migration of hepatocellular carcinoma MHCC-97H cells].
Yao B; Xue Y; Liu Z; Xu M; Tu K; Wang J
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Aug; 32(8):1083-7. PubMed ID: 27412940
[TBL] [Abstract][Full Text] [Related]
40. MicroRNA‑944 targets vascular endothelial growth factor to inhibit cell proliferation and invasion in osteosarcoma.
Yan T; Zhu S; Zhang J; Lu G; Lv C; Wei Y; Luo M
Mol Med Rep; 2018 Dec; 18(6):5221-5228. PubMed ID: 30280196
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
